Valuation: Middle East Pharmaceutical Industries Company

Market Cap 2.25B 600M 526M 495M 452M 845M 57.45B 852M 5.94B 2.3B 29.29B 2.2B 94.97B P/E 2024
30.5x
P/E 2025 22.9x
Enterprise Value 2.28B 608M 533M 501M 458M 856M 58.2B 863M 6.02B 2.33B 29.67B 2.23B 96.21B EV / Sales 2024
6.29x
EV / Sales 2025 4.89x
Free-Float
46.88%
Yield 2024
1.64%
Yield 2025 2.18%
1 day-0.23%
1 week-1.23%
Current month-5.59%
1 month+2.31%
3 months+5.25%
6 months+14.82%
Current year+1.03%
1 week 63.7
Extreme 63.7
64.95
1 month 61.75
Extreme 61.75
68.1
Current year 53.89
Extreme 53.885712
68.51
1 year 53.89
Extreme 53.885712
79.09
3 years 51.54
Extreme 51.542856
112.91
5 years 51.54
Extreme 51.542856
112.91
10 years 51.54
Extreme 51.542856
112.91
Manager TitleAgeSince
Chief Executive Officer 45 2018-09-04
Director of Finance/CFO - 2024-03-10
Chief Tech/Sci/R&D Officer 51 2022-12-31
Director TitleAgeSince
Chairman 54 2022-04-09
Director/Board Member 45 2023-09-12
Director/Board Member 45 2022-04-09
Change 5-day change 1-year change 3-year change Capi.($)
-0.23%-1.23%-10.26% - 600M
-0.81%-0.93%+13.69%+64.57% 46.71B
-0.72%-1.74%+36.01%+105.43% 36.9B
+0.87%+3.98%+13.93%+95.62% 12.18B
+1.16%+1.65%-9.04%+18.62% 11.66B
+0.19%-0.95%+20.37%+140.74% 8.97B
-1.80%+0.60%+20.40%+209.39% 7.29B
-0.71%-1.56%+26.56%+38.62% 7.21B
+0.77%+0.71%+39.69%-15.42% 7.09B
-0.64%+4.03%-43.43%+10.76% 5.12B
Average -0.19%+1.25%+10.79%+74.26% 14.37B
Weighted average by Cap. -0.38%+0.68%+18.15%+78.96%

Financials

2024 2025
Net sales 394M 105M 92.09M 86.56M 79.14M 148M 10.05B 149M 1.04B 403M 5.12B 385M 16.61B 460M 123M 108M 101M 92.5M 173M 11.75B 174M 1.22B 471M 5.99B 450M 19.42B
Net income 79.85M 21.26M 18.66M 17.54M 16.04M 29.97M 2.04B 30.19M 211M 81.69M 1.04B 78.1M 3.37B 97.01M 25.83M 22.67M 21.31M 19.49M 36.41M 2.47B 36.68M 256M 99.24M 1.26B 94.88M 4.09B
Net Debt 42.83M 11.41M 10.01M 9.41M 8.6M 16.08M 1.09B 16.2M 113M 43.82M 557M 41.89M 1.81B 29.47M 7.85M 6.89M 6.48M 5.92M 11.06M 752M 11.14M 77.78M 30.15M 383M 28.83M 1.24B
Logo Middle East Pharmaceutical Industries Company
Middle East Pharmaceutical Industries Company SJSC is a Saudi Arabia-based pharmaceutical company. The Company develops, manufactures, markets, and distributes a wide range of generic medicines and pharmaceuticals. The Company’s activity is the manufacture of disinfectants and sterilizers for medical devices and products, the manufacture of disinfectants and sterilizers for non-medical use, the manufacture of cosmetics, and the manufacture of pharmaceutical preparations for human use.
Employees
731
Date Price Change Volume
26-09-24 SAR 64.20 -0.23% 33,096
26-09-22 SAR 64.35 +0.70% 21,715
26-09-21 SAR 63.90 -0.62% 11,060
26-09-20 SAR 64.30 -1.08% 41,171
26-09-17 SAR 65.00 +2.28% 128,435
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
64.35SAR
Average target price
146.40SAR
Spread / Average Target
+127.51%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4016 Stock